Recombinase activating gene 2 deficiency: genes and variants
Explore variant evidence for Recombinase activating gene 2 deficiency across 1 analyzed protein (RAG2). Linked ClinVar records include 25 pathogenic or likely pathogenic variants, 19 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Recombinase activating gene 2 deficiency
RAG2: V(D)J recombination-activating protein 2
Together with RAG1, it restricts and activates V(D)J recombination during lymphocyte development so immunoglobulin and T-cell receptor genes can be assembled. Biallelic loss-of-function variants cause severe combined immunodeficiency or hypomorphic immune-dysregulation syndromes.
25 ClinVar pathogenic / likely pathogenic and 22 uncertain variants in RAG2 have source records linked to Recombinase activating gene 2 deficiency. Association strength is not clinical gene validity.
Where Recombinase activating gene 2 deficiency variants cluster
- RAG2 PHD-type (positions 416–484): 11 of 25 ClinVar pathogenic / likely pathogenic variants, 3.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Recombinase activating gene 2 deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| RAG2 R229W | 229 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 R229Q | 229 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 C446W | 446 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 W453R | 453 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 R73C | 73 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 G95R | 95 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 W416L | 416 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 E437K | 437 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 D65Y | 65 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 I444M | 444 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 G35A | 35 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 R39G | 39 | Pathogenic / likely pathogenic (★★★) | |
| RAG2 G451A | 451 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 L466F | 466 | PHD-type | Pathogenic / likely pathogenic (★★★) |
| RAG2 C41W | 41 | Pathogenic / likely pathogenic (★★) | |
| RAG2 P180H | 180 | Pathogenic / likely pathogenic (★★) | |
| RAG2 M285R | 285 | Pathogenic / likely pathogenic (★★) | |
| RAG2 T77N | 77 | Pathogenic / likely pathogenic (★★) | |
| RAG2 A442T | 442 | PHD-type | Pathogenic / likely pathogenic (★) |
| RAG2 M443I | 443 | PHD-type | Pathogenic / likely pathogenic (★) |
| RAG2 A456T | 456 | PHD-type | Pathogenic / likely pathogenic (★) |
| RAG2 F62L | 62 | Pathogenic / likely pathogenic (★) | |
| RAG2 G157V | 157 | Pathogenic / likely pathogenic (★) | |
| RAG2 Y195D | 195 | Pathogenic / likely pathogenic (★) | |
| RAG2 K440N | 440 | PHD-type | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Recombinase activating gene 2 deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- SIFT: 100 out of 100
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 97 out of 100
- AlphaMissense: 94 out of 100
- phyloP: 90 out of 100
- ESM1b (LLR): 74 out of 100
- Pangolin: 74 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Combined immunodeficiency with skin granulomas also has ClinVar records linked to RAG2 variants; they fall partly in the same places as the Recombinase activating gene 2 deficiency variants (33 pathogenic / likely pathogenic).
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive also has ClinVar records linked to RAG2 variants; they fall partly in the same places as the Recombinase activating gene 2 deficiency variants (32 pathogenic / likely pathogenic).
- Histiocytic medullary reticulosis also has ClinVar records linked to RAG2 variants; they fall in the same places as the Recombinase activating gene 2 deficiency variants (14 pathogenic / likely pathogenic).
- Severe combined immunodeficiency also has ClinVar records linked to RAG2 variants; they fall partly in the same places as the Recombinase activating gene 2 deficiency variants (7 pathogenic / likely pathogenic).
Diseases related to Recombinase activating gene 2 deficiency
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, also linked to RAG2
- Combined immunodeficiency with skin granulomas, also linked to RAG2
- Severe combined immunodeficiency, also linked to RAG2
- Histiocytic medullary reticulosis, also linked to RAG2
- Inborn error of immunity, also linked to RAG2
- Common variable immunodeficiency, also linked to RAG2
Frequently asked questions
Which genes have records linked to Recombinase activating gene 2 deficiency?
This view contains 1 analyzed proteins: RAG2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 25 pathogenic or likely pathogenic variants, 19 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 61 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center